Looking to the Future of Early Detection in Cancer: Liquid Biopsies, Imaging, and Artificial Intelligence.

Abstract

Authors

• Stefan Foser
  Vice President, Head in Center of Diagnostics for Innovation Oncology, Siemens Healthcare Diagnostics Products GmbH, Cologne, Germany.
• Kenneth Maiese
  Vice President of Medical Affairs, Diagnostics Research, Development, and Innovation, Siemens Healthcare Diagnostics, Tarrytown, NY, United States.
• Subba R Digumarthy
  Massachusetts General Hospital, Department of Radiolgoy, United States.
• Joan Anton Puig-Butille
  Head of Molecular Biology CORE, Biomedical Diagnostic Center (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.
• Christian Rebhan
  President, Scientific Business Units & Chief Medical Officer, Unilabs, Geneva, Switzerland.

Keywords

External Resources